Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118714845 | 11871484 | 5 | F | 20150915 | 20160722 | 20151228 | 20160801 | EXP | CA-PFIZER INC-2015138517 | PFIZER | 65.00 | YR | M | Y | 0.00000 | 20160801 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118714845 | 11871484 | 1 | PS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 5 MG, DAILY | Y | 203214 | 5 | MG | TABLET | ||||||
| 118714845 | 11871484 | 2 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 5 MG, 2X/DAY | Y | 203214 | 5 | MG | TABLET | BID | |||||
| 118714845 | 11871484 | 3 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 5 MG, 1X/DAY | Y | 203214 | 5 | MG | TABLET | QD | |||||
| 118714845 | 11871484 | 4 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 5 MG, 2X/DAY | Y | 203214 | 5 | MG | TABLET | BID | |||||
| 118714845 | 11871484 | 5 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Subcutaneous | 20 MG, WEEKLY | Y | 11719 | 20 | MG | SOLUTION FOR INJECTION | /wk |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118714845 | 11871484 | 1 | Rheumatoid arthritis |
| 118714845 | 11871484 | 5 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118714845 | 11871484 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118714845 | 11871484 | Arthropathy | |
| 118714845 | 11871484 | Blister | |
| 118714845 | 11871484 | Bronchitis | |
| 118714845 | 11871484 | Condition aggravated | |
| 118714845 | 11871484 | Cyst | |
| 118714845 | 11871484 | Erythema | |
| 118714845 | 11871484 | Gait disturbance | |
| 118714845 | 11871484 | Hepatic enzyme increased | |
| 118714845 | 11871484 | Hepatic fibrosis | |
| 118714845 | 11871484 | Laryngitis | |
| 118714845 | 11871484 | Musculoskeletal chest pain | |
| 118714845 | 11871484 | Nasopharyngitis | |
| 118714845 | 11871484 | Precancerous skin lesion | |
| 118714845 | 11871484 | Productive cough | |
| 118714845 | 11871484 | Pruritus | |
| 118714845 | 11871484 | Pyrexia | |
| 118714845 | 11871484 | Rheumatoid arthritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118714845 | 11871484 | 1 | 20150116 | 20150310 | 0 | |
| 118714845 | 11871484 | 2 | 20150311 | 20150915 | 0 | |
| 118714845 | 11871484 | 3 | 201601 | 20160218 | 0 | |
| 118714845 | 11871484 | 4 | 20160219 | 20160614 | 0 | |
| 118714845 | 11871484 | 5 | 201506 | 0 |